Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Parathormone (human recombinant)

Known as: parathyroid hormone (1-84) human recombinant, rhPTH, rhPTH(1-84) 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND Impaired mineral homeostasis affecting calcium, phosphate, and magnesium is a result of parathyroid hormone (PTH… Expand
  • table I
  • figure 1
  • table II
  • figure 2
  • table III
Is this relevant?
2013
2013
BACKGROUND Recombinant human parathyroid hormone (1-34) (rhPTH (1-34)) is the first agent in a unique class of anabolic therapies… Expand
Is this relevant?
Review
2012
Review
2012
  • K Lippuner
  • Swiss medical weekly
  • 2012
  • Corpus ID: 36985145
Osteoporosis is characterised by a progressive loss of bone mass and microarchitecture which leads to increased fracture risk… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 1
  • figure 2
Is this relevant?
2011
2011
We compared teriparatide (TPTD) and strontium ranelate (SR) efficacy on bone formation activity in a mature rat model of estrogen… Expand
Is this relevant?
2010
2010
Kümmell’s disease is the current eponym of avascular osteonecrosis (AVN) of a vertebral body leading to a delayed non-healing… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
Since the approval of teriparatide for clinical application, a number of iliac crest studies have focused on increases in bone… Expand
Is this relevant?
2009
2009
SummaryThe level of increased bone formation after 24 months of treatment with teriparatide (rhPTH (1–34), TPTD) is similar in… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2007
2007
OBJECTIVE Teriparatide [rhPTH (1-34)] is an effective treatment for osteoporosis administered by daily subcutaneous injection… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2006
2006
IntroductionTeriparatide [rhPTH (1–34)] reduces fracture risk, and in a published meta-analysis of clinical trials, teriparatide… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
INTRODUCTION We evaluated effects of teriparatide (rDNA origin) injection [teriparatide, rhPTH (1-34), TPTD] on hip structure… Expand
Is this relevant?